March 29 - Apr 3, 2019
Georgia World Congress Center
Atlanta, Georgia, USA
Abstract submission deadline: Thursday, January 10
Advance registration deadline: Monday, January 28
Late-breaking AbstractsThe deadline for late-breaking abstracts was 11:59 p.m. U.S. ET, Thursday, Jan. 10, 2019. Abstracts detailing highly significant and timely findings in any area of cancer research that were not available at the time of the regular abstract deadline were considered for presentation at the Annual Meeting. Only those abstracts deemed to be of high scientific priority were accepted.
Clinical Trials AbstractsAll abstracts describing clinical trials (including placeholder abstracts) should be submitted as late-breaking abstracts. The deadline for clinical trials abstracts was 11:59 p.m. U.S. ET, Thursday, Jan. 10, 2019. Final data for placeholder abstracts were due
Friday, Feb. 1, 2019.
Learn more about Clinical Trials Abstract submission.
Deadline for Withdrawal of Abstracts The AACR cannot comply with any request for withdrawal of an abstract that will delay the publication of the
Proceedings. However, requests to withdraw abstracts were accepted through
Friday, Feb. 1, 2019. Requests to withdraw late-breaking abstracts were accepted through
Thursday, Feb. 28, 2019. Withdrawal requests must be sent by email to
firstname.lastname@example.org. Withdrawal requests must include the Abstract Control Number and title as well as an explanation of the reason for withdrawal.
Notifications of Regular Abstract StatusStatus notifications for regular abstracts was emailed to the presenting authors Thursday, Jan. 24, 2019.
Embargo Policy and Online Publication of AbstractsIn accordance with the AACR’s embargo policy, the content of abstracts must be kept confidential until they are made publicly available:
Presentation of Proffered Papers at the AACR Annual MeetingEvery proffered abstract that has been accepted for publication in the
Proceedings must have a corresponding presentation at the meeting. Specifically, the author listed as the presenter for an accepted proffered paper must attend the corresponding session to discuss in detail the research outlined in the published abstract, according to the specific guidelines of the session. If, due to unforeseen circumstances, the designated presenter is unavailable to attend the session to present the paper, he or she must contact the AACR Program Development Department to designate a coauthor to serve as the presenter. If no abstract authors are available to present the data, they must withdraw the abstract immediately by contacting the AACR Program Development Department at
Failure to comply with these regulations pertaining to abstract presentation may result in actions including, but not limited to:
Top of page